🇺🇸 FDA
Patent

US 9938526

Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation

granted A61KA61K31/7088A61K31/713

Quick answer

US patent 9938526 (Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation) held by The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024)
Grant date
Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/7088, A61K31/713, A61K47/541, A61K47/547